Alternative Financing Strategies For Medtech Start-Ups
By
Mary Stuart / Email the Author / START-UP January 2012, Vol. 17, No. 1
Feature Articles / Word Count: 5288 / Article # 2012900018
Executive Summary
Pools of venture capital for life science companies are drying up. The good news is that there are alternative sources for young medtech companies. EBI convened a panel of experts at its recent IN3 conference to explain when and where to find them and presents here a Q&A with an angel investor, a representative from a venture debt firm, and an expert in non-dilutive grant funding.
$125.00
Buy Now
For $125.00, purchase this 5288-word article and receive immediate online access. 100% Satisfaction Guarantee.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.